APA
Gray J. E., Okamoto I., Sriuranpong V., Vansteenkiste J., Imamura F., Lee J. S., Pang Y., Cobo M., Kasahara K., Cheng Y., Nogami N., Cho E. K., Su W. C., Zhang G., Huang X., Li-Sucholeiki X., Lentrichia B., Dearden S., Jenkins S., Saggese M., Rukazenkov Y. & Ramalingam S. S. (20200910). Tissue and Plasma EGFR Mutation Analysis in the FLAURA Trial: Osimertinib versus Comparator EGFR Tyrosine Kinase Inhibitor as First-Line Treatment in Patients with EGFR-Mutated Advanced Non-Small Cell Lung Cancer. : Clinical cancer research : an official journal of the American Association for Cancer Research.
Chicago
Gray Jhanelle E, Okamoto Isamu, Sriuranpong Virote, Vansteenkiste Johan, Imamura Fumio, Lee Jong Seok, Pang Yong-Kek, Cobo Manuel, Kasahara Kazuo, Cheng Ying, Nogami Naoyuki, Cho Eun Kyung, Su Wu Chou, Zhang Guili, Huang Xiangning, Li-Sucholeiki Xiaocheng, Lentrichia Brian, Dearden Simon, Jenkins Suzanne, Saggese Matilde, Rukazenkov Yuri and Ramalingam Suresh S. 20200910. Tissue and Plasma EGFR Mutation Analysis in the FLAURA Trial: Osimertinib versus Comparator EGFR Tyrosine Kinase Inhibitor as First-Line Treatment in Patients with EGFR-Mutated Advanced Non-Small Cell Lung Cancer. : Clinical cancer research : an official journal of the American Association for Cancer Research.
Harvard
Gray J. E., Okamoto I., Sriuranpong V., Vansteenkiste J., Imamura F., Lee J. S., Pang Y., Cobo M., Kasahara K., Cheng Y., Nogami N., Cho E. K., Su W. C., Zhang G., Huang X., Li-Sucholeiki X., Lentrichia B., Dearden S., Jenkins S., Saggese M., Rukazenkov Y. and Ramalingam S. S. (20200910). Tissue and Plasma EGFR Mutation Analysis in the FLAURA Trial: Osimertinib versus Comparator EGFR Tyrosine Kinase Inhibitor as First-Line Treatment in Patients with EGFR-Mutated Advanced Non-Small Cell Lung Cancer. : Clinical cancer research : an official journal of the American Association for Cancer Research.
MLA
Gray Jhanelle E, Okamoto Isamu, Sriuranpong Virote, Vansteenkiste Johan, Imamura Fumio, Lee Jong Seok, Pang Yong-Kek, Cobo Manuel, Kasahara Kazuo, Cheng Ying, Nogami Naoyuki, Cho Eun Kyung, Su Wu Chou, Zhang Guili, Huang Xiangning, Li-Sucholeiki Xiaocheng, Lentrichia Brian, Dearden Simon, Jenkins Suzanne, Saggese Matilde, Rukazenkov Yuri and Ramalingam Suresh S. Tissue and Plasma EGFR Mutation Analysis in the FLAURA Trial: Osimertinib versus Comparator EGFR Tyrosine Kinase Inhibitor as First-Line Treatment in Patients with EGFR-Mutated Advanced Non-Small Cell Lung Cancer. : Clinical cancer research : an official journal of the American Association for Cancer Research. 20200910.